Citi maintains a 'Buy' rating on The Medicines Company (Nasdaq: MDCO), adds stock to Top Picks Live list. Price ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE